Inactivating NF1 Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance. (2020)
Attributed to:
MICA: Using circulating tumour DNA to identify and predict mechanisms of resistance to targeted cancer therapies.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-18-4044
PubMed Identifier: 31591187
Publication URI: http://europepmc.org/abstract/MED/31591187
Type: Journal Article/Review
Volume: 26
Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research
Issue: 3
ISSN: 1078-0432